Perioperative activin A concentrations as a predictive marker of neurologic abnormalities in children after open heart surgery

Clinical Chemistry

Volumn 53, Issue 5, 2007, Pages 982-985

  Florio, Pasquale ^a   Abella, Raul Felipe ^b   De La Torre, Teresa ^b   Giamberti, Alessandro ^b   Luisi, Stefano ^a   Butera, Gianfranco ^b   Cazzaniga, Alessandro ^b   Frigiola, Alessandro ^b   Petraglia, Felice ^a   Gazzolo, Diego ^c,d  

^a UNIVERSITY OF SIENA   (Italy)

^b University Hospital   (Italy)

^c G GASLINI INSTITUTE   (Italy)

^d GARIBALDI HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN A;

ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONGENITAL HEART MALFORMATION; DIAGNOSTIC ACCURACY; DISEASE MARKER; FEMALE; HUMAN; INFANCY; INFANT; MALE; NERVOUS SYSTEM DEVELOPMENT; NERVOUS SYSTEM INJURY; OPEN HEART SURGERY; OUTCOME ASSESSMENT; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PREDICTIVE VALIDITY; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SURGICAL TECHNIQUE;

ACTIVINS; BIOLOGICAL MARKERS; BRAIN DISEASES; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; CASE-CONTROL STUDIES; FEMALE; HEART DEFECTS, CONGENITAL; HUMANS; IMMUNOASSAY; INFANT; INTRAOPERATIVE CARE; MALE; PREDICTIVE VALUE OF TESTS; REPERFUSION INJURY;

EID: 34248334517     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2006.077149     Document Type: Article

References (20)

1. Bellinger DC, Jonas RA, Rappaport LA, Wypij D, Wernovsky G, Kuban KC, et al. Developmental and neurologic status of children after heart surgery with hypothermic circulatory arrest or low-flow cardiopulmonary bypass. N Engl J Med 1995;332:549-55.
2. Lundar T, Lindberg H, Lindegaard KF, Tjonneland S, Rian R, Bo G, et al. Cerebral perfusion during major cardiac surgery in children. Pediatr Cardiol 1987;8:161-5.
3. Ingebrigtsen T, Romner B. Biochemical serum markers for brain damage: A short review with emphasis on clinical utility in mild head injury. Restor Neurol Neurosci 2003;21:171-6.
4. Florio P, Gazzolo D, Luisi S, Petraglia F. Activin in brain injury. Adv Clin Chem 2007;43:117-30.
5. Luisi S, Florio P, Reis FM, Petraglia F. Expression and secretion of activin A: possible physiological and clinical implications. Eur J Endocrinol 2001;145: 225-36.
6. Iwahori Y, Saito H, Torii K, Nishiyama N. Activin exerts a neurotrophic effect on cultured hippocampal neurons. Brain Res 1997;760:52-8.
7. Krieglstein K, Suter-Crazzolara C, Fischer WH, Unsicker K. TGF-beta super-family members promote survival of midbrain dopaminergic neurons and protect them against MPP+ toxicity. EMBO J 1995;14:736-42.
8. Wu DD, Lai M, Hughes PE, Sirimanne E, Gluckman PD, Williams CE. Expression of the activin axis and neuronal rescue effects of recombinant activin A following hypoxic-ischemic brain injury in the infant rat. Brain Res 1999;835:369-78.
9. Hughes PE, Alexi T, Williams CE, Clark RG, Gluckman PD. Administration of recombinant human Activin-A has powerful neurotrophic effects on select striatal phenotypes in the quinolinic acid lesion model of Huntington's disease. Neuroscience 1999;92:197-209.
10. Florio P, Perrone S, Luisi S, Longini M, Tanganelli D, Petraglia F, et al. Activin A plasma levels at birth: an index of fetal hypoxia in preterm newborn. Pediatr Res 2003;54:696-700.
11. Florio P, Perrone S, Luisi S, Vezzosi P, Longini M, Marzocchi B, et al. Increased plasma concentrations of activin A predict intraventricular hemorrhage in preterm newborns. Clin Chem 2006;52:1516-21.
12. Florio P, Luisi S, Bruschettini M, Grutzfeld D, Dobrzanska A, Bruschettini P, et al. Cerebrospinal fluid activin A measurement in asphyxiated full-term newborns predicts hypoxic ischemic encephalopathy. Clin Chem 2004;50: 2386-9.
13. Gosselin J, Gahagan S, Amiel-Tison C. The Amiel-Tison Neurological Assessment at Term: conceptual and methodological continuity in the course of follow-up. Ment Retard Dev Disabil Res Rev 2005;11:34-51.
14. Stephan C, Wesseling S, Schink T, Jung K. Comparison of eight computer programs for receiver-operating characteristic analysis. Clin Chem 2003;49: 433-9.
15. Richardson WS, Wilson MC, Guyatt GH, Cook DJ, Nishikawa J. Users' guides to the medical literature: XV. How to use an article about disease probability for differential diagnosis. Evidence-based medicine working group. JAMA 1999;281:1214-9.
16. Florio P, Reis FM, Severi FM, Luisi S, Imperatore A, Palumbo MA, et al. Umbilical cord serum activin A levels are increased in pre-eclampsia with impaired blood flow in the uteroplacental and fetal circulation. Placenta 2006;27:432-7.
17. Petraglia F, Gomez R, Luisi S, Florio P, Tolosa JE, Stomati M, et al. Increased midtrimester amniotic fluid activin A: a risk factor for subsequent fetal death. Am J Obstet Gynecol 1999;180:194-7.
18. Ebert S, Phillips DJ, Jenzewski P, Nau R, O'Connor AE, Michel U. Activin A concentrations in human cerebrospinal fluid are age-dependent and elevated in meningitis. J Neurol Sci 2006;250:50-7.
19. Phillips DJ, Nguyen P, Adamides AA, Bye N, Rosenfeld JV, Kossmann T, et al. Activin A release into cerebrospinal fluid in a subset of patients with severe traumatic brain injury. J Neurotrauma 2006;23:1283-94.
20. du Plessis AJ, Treves ST, Hickey PR, O'Tuama L, Barlow CF, Costello J, et al. Regional cerebral perfusion abnormalities after cardiac operations. Single photon emission computed tomography (SPECT) findings in children with postoperative movement disorders. J Thorac Cardiovasc Surg 1994;107: 1036-43.